Editorial
Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer : state of the art
Controversies regarding screening for prostate cancer
Is the era of prostate-specific antigen over?
Current prostate cancer : 20 years later
Chemoprevention of prostate cancer : lessons learned
Chemotherapy of premalignant lesions : new insights
European Study of Radical Prostatectomy : time trends in Europe, 1993–2005
Active surveillance vs radical prostatectomy
How to preserve potency and continence in localized prostate cancer
Definition and management of prostate-specific antigen recurrence after local therapy
Is hormone ablation still the right choice for advanced prostate cancer?
Adjuvant treatment to surgery
Adjuvant treatment to radiation : combined hormone therapy and external radiotherapy for locally advanced prostate cancer
Multiple intracrine hormonal targets in the prostate : opportunities and challenges
Molecular aspects of hormone-independent prostate cancer
Hormone-refractory prostate cancer : what have we learned?
Combination of somatostatin analogues and dexamethasone (antisurvival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis